ATP2B4 and Hypertension: They provide additional evidence for the hypothesis that PMCA4b functions as a signaling molecule, and given that PMCA4b modulates the development of cardiac hypertrophy, its interaction with renalase may have particular clinical relevance for patients with hypertension and chronic kidney disease.